- Home
- FRT vs ROIV Comparison
FRT vs ROIV Comparison
Compare FRT & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRT
- ROIV
- Stock Information
- Founded
- FRT 1962
- ROIV 2014
- Country
- FRT United States
- ROIV United Kingdom
- Employees
- FRT N/A
- ROIV N/A
- Industry
- FRT Real Estate Investment Trusts
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- FRT Real Estate
- ROIV Health Care
- Exchange
- FRT Nasdaq
- ROIV Nasdaq
- Market Cap
- FRT 8.2B
- ROIV 7.8B
- IPO Year
- FRT N/A
- ROIV N/A
- Fundamental
- Price
- FRT $94.51
- ROIV $10.95
- Analyst Decision
- FRT Buy
- ROIV Buy
- Analyst Count
- FRT 13
- ROIV 4
- Target Price
- FRT $114.46
- ROIV $17.50
- AVG Volume (30 Days)
- FRT 651.0K
- ROIV 6.7M
- Earning Date
- FRT 08-06-2025
- ROIV 08-07-2025
- Dividend Yield
- FRT 4.67%
- ROIV N/A
- EPS Growth
- FRT 23.89
- ROIV N/A
- EPS
- FRT 3.47
- ROIV N/A
- Revenue
- FRT $1,223,588,000.00
- ROIV $29,053,000.00
- Revenue This Year
- FRT $5.34
- ROIV $2.64
- Revenue Next Year
- FRT $5.51
- ROIV $378.09
- P/E Ratio
- FRT $27.11
- ROIV N/A
- Revenue Growth
- FRT 6.05
- ROIV N/A
- 52 Week Low
- FRT $80.65
- ROIV $8.73
- 52 Week High
- FRT $118.34
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- FRT 43.86
- ROIV 48.29
- Support Level
- FRT $93.24
- ROIV $11.32
- Resistance Level
- FRT $95.89
- ROIV $11.82
- Average True Range (ATR)
- FRT 1.47
- ROIV 0.33
- MACD
- FRT -0.20
- ROIV -0.03
- Stochastic Oscillator
- FRT 13.38
- ROIV 30.27
About FRT Federal Realty Investment Trust
Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 26.8 million square feet of retail space and over 3,100 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.